Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Ji-Huan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Fengcheng Hospital of Fengxian District, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Relaxin, Microglia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aims to assess the therapeutic effectiveness of Relaxin‐2 (RLN‐2) in promoting functional recovery and neuroprotection following spinal cord injury (SCI) in mice. Furthermore, continuous subcutaneous infusion of Serelaxin (0.5 mg/kg/day; human recombinant relaxin‐2) improved neurological recovery, as evidenced by higher Basso‐Beattie‐Bresnahan (BBB) scores and reduced foot‐stepping angles compared to the SCI group. Additionally, RLN‐2 effectively reduced edema in the injured spinal cord, as shown by decreased water content and downregulated AQP4 expression at mRNA and protein levels. RLN‐2 reduced oxidative stress markers such as malondialdehyde (MDA) and reactive oxygen species (ROS) and increased the activity of catalase (CAT). Further, RLN‐2 mitigated neuroinflammation by reducing the levels of pro‐inflammatory cytokines (TNF‐α and IL‐6) and by inhibiting the activation of M1 microglia while promoting the polarization of M2 microglia. It also inhibited the activation of the NF‐κB signaling and strengthened the activation of the STAT6 signaling in the spinal cord of SCI mice. These findings suggest that RLN‐2 may be a promising therapeutic agent for the treatment of spinal cord injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Fengcheng Hospital of Fengxian District, Shanghai, People's Republic of China.
ORCID-Profile: Ji-Huan Wang
Zitieren
APA
Wang, J. H., Sheng, H. B., & Li, J. K. (2025). Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70041
Vancouver
Wang JH, Sheng HB, Li JK. Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70041
BibTeX
@article{Wang2025,
author = {Wang, Ji-Huan and Sheng, Hong-Biao and Li, Jun-Kun},
title = {Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70041}
}
EUVIMED